Predict your next investment

Aesculap Implant Systems company logo
HEALTHCARE | Medical Devices & Equipment / Prosthetics
aesculapimplantsystems.com

See what CB Insights has to offer

About Aesculap Implant Systems

Aesculap Implant Systems is a medical device company developing: Activ-L Artificial Disc.Aesculap Implant Systems offer a complete line of high-tech implant systems and instrumentation for both the Spine and Orthopaedic markets. Spine products and orthopaedic products are just a few of the implant systems from Aesculap.

Aesculap Implant Systems Headquarter Location

3773 Corporate Parkway

Center Valley, Pennsylvania, 18034,

United States

Latest Aesculap Implant Systems News

15:51 ET Aesculap Implant Systems Announces the Long-Term Reporting from its Pivotal IDE Trial for the activL® Artificial Disc

Jul 26, 2021

Share this article Share this article CENTER VALLEY, Pa., July 26, 2021 /PRNewswire/ -- Aesculap Implant Systems, LLC, a leader in lumbar motion preservation technology, today announced the e-publication of the "Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease, 7-Year Results" in the International Journal of Spine Surgery. The study reports patient outcomes at seven years post procedure, comparing the activL Artificial Disc, the latest generation lumbar total disc replacement (TDR), with the previous generation disc replacement system – ProDisc-L – in the treatment of patients with symptomatic single-level lumbar degenerative disc disease (DDD). activL Artificial Disc with Intelligent Motion Technology The activL Artificial Disc is designed to preserve motion at a single level (L4-L5 or L5-S1) of the spine by replicating the performance of the intact intervertebral disc. The long-term evidence from the FDA non-inferiority study presented in this paper supports lumbar TDR as a safe and effective treatment option for DDD. At seven years, the activL Artificial Disc demonstrates prolonged significant improvements in back/leg pain, disability index and quality-of-life relative to baseline. Additionally, the study shows that activL Artificial Disc patients have significantly better range of motion (ROM) for flexion-extension rotation than ProDisc-L patients (p=0.033) at seven years and that significantly fewer activL Disc patients report serious safety issues than ProDisc-L patients (p=0.011). Predictive modeling demonstrates that most patients lost to follow-up at two years have clinically significant benefits with the activL Artificial Disc at seven years if improvements are made at two years. "This publication represents the longest follow-up of patients from a lumbar arthroplasty IDE Trial and proves without a doubt the safety and efficacy of lumbar disc arthroplasty," said Kris Radcliff, MD (Rothman Orthopedic Institute, Philadelphia Pennsylvania). "I am proud to offer my patients this technology as an alternative to fusion." "Aesculap continues to see significant benefits toward quality of life with the activL Artificial Disc. The latest evidence of patient outcomes from our randomized controlled trial demonstrates the long-term impact of the technology," said Charles DiNardo, President of Aesculap Implant Systems. "We see first-hand the impact lumbar arthroplasty has in returning patients' quality of life and are hopeful that the seven-year data presented in this publication will provide the long-term evidence needed to further improve access to patients with DDD." The full text can be found on the IJSS website ( www.ijssurgery.com ) About Aesculap Implant Systems, LLC Aesculap Implant Systems, LLC, a B. Braun company, is part of a 175-year-old global organization focused on meeting the needs of the changing healthcare environment. Through close collaboration with its customers, Aesculap Implant Systems develops advanced spine and orthopaedic implant technologies to treat complex disorders of the spine, hip and knee. Aesculap Implant Systems strives to deliver products and services that improve the quality of patients' lives. For more information, call 800-234-9179 or visit  aesculapimplantsystems.com . SOURCE Aesculap Implant Systems, LLC ×

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Aesculap Implant Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Aesculap Implant Systems is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Aesculap Implant Systems Patents

Aesculap Implant Systems has filed 77 patents.

The 3 most popular patent topics include:

  • Orthopedic surgical procedures
  • Bones of the vertebral column
  • Spinal nerves
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/1/2019

4/20/2021

Orthopedic surgical procedures, Bones of the vertebral column, Surgical instruments, Spinal nerves, Surgical removal procedures

Grant

Application Date

4/1/2019

Grant Date

4/20/2021

Title

Related Topics

Orthopedic surgical procedures, Bones of the vertebral column, Surgical instruments, Spinal nerves, Surgical removal procedures

Status

Grant

Aesculap Implant Systems Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Aesculap Implant Systems Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.